Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2025)

ENDRA Life Sciences has reported Share-based Compensation over the past 6 years, most recently at $411737.0 for Q4 2021.

  • Quarterly Share-based Compensation fell 24.19% to $411737.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2021, down 31.29% year-over-year, with the annual reading at $186287.0 for FY2025, 67.43% down from the prior year.
  • Share-based Compensation was $411737.0 for Q4 2021 at ENDRA Life Sciences, up from $327799.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $546040.0 in Q2 2020 and troughed at $29698.0 in Q1 2017.
  • The 5-year median for Share-based Compensation is $365571.5 (2018), against an average of $365859.5.
  • The largest YoY upside for Share-based Compensation was 2972.07% in 2017 against a maximum downside of 62.04% in 2017.
  • A 5-year view of Share-based Compensation shows it stood at $402443.0 in 2017, then dropped by 23.53% to $307750.0 in 2018, then increased by 23.23% to $379247.0 in 2019, then skyrocketed by 43.21% to $543120.0 in 2020, then decreased by 24.19% to $411737.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Share-based Compensation are $411737.0 (Q4 2021), $327799.0 (Q3 2021), and $383087.0 (Q2 2021).